Physician profile
James Lew
NPI 1629177506
$9,739.49
in general payments reported to CMS, 2019-2025
44 companies · $1,614 in 2025
The $1,614 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,638 · 2020: $376 · 2021: $875 · 2022: $1,025 · 2023: $2,326 · 2024: $1,886 · 2025: $1,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,826.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,215.18 | 2019-2025 | |
| Novo Nordisk INC | $1,109.31 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $996.92 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $977.34 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $808.32 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $739.81 | 2019-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $682.12 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $513.54 | 2019-2025 | |
| Abbott Laboratories | $402.98 | 2022-2023 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $299.94 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $264.54 | 2019-2025 | |
| Allergan, INC. | $227.91 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $190.52 | 2023 | Quviviq |
| Mylan Specialty L.P. | $188.49 | 2023-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $165.41 | 2019-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.